Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Spain

 

GHX sells to Thoma Bravo

GHX, the world's leading eCommerce and exchange platform for medtech products, has been bought from a consortium of 20 suppliers and providers by tech-focused US private equity house Thoma Bravo. What ramifications will this have for transparency in procurement? We talk to Bruce Johnson, GHX CEO, and look at the price of the deal.

Bribery in healthcare

The vast majority of bribes paid by citizens in Europe have to do with access to healthcare, according to an EU anti-corruption report. Healthcare and pharma businesses in Europe are also the most likely of any industry, with 77% agreeing, to think that corruption is widespread in their country. The report puts the total cost of corruption in the EU at €120bn - a little less than the annual EU budget. We look at the underlying numbers.

Interview: Mark Hellowell, Lecturer, University of Edinburgh

Hellowell is a healthcare academic who specialises in PPPs, evaluating their performance around the world, consulting with development agencies and acting as a special adviser to the Health Select Committee in the British House of Commons. He also lectures on healthcare reform to a diverse group of postgraduate students, many of them from developing countries. We talk to him about the role private healthcare companies can, and are, playing in the developing and developed worlds, the future for PPPs, and whether they are “a good thing”.

3i buys into discount gym sector

3i has invested €110m in Basic-Fit, which runs 200 discount gyms aross Benelux, Spain and France. The group is part of a new generation of gyms, which are one-third to half the price of the traditional players.

Americans scour Europe

US property investors are getting much more adventurous. Some are considering investing in Greek and Spanish hospital groups. We look at why and how they will invest.

Vitaldent to hit Poland

Vitaldent, the big family-owned dentistry chain operating across Spain and Italy, has taken out a €100m loan with Intermediate Capital Group. The group plans to grow sales nearly 50% over the next five years to €650m. It plans to do this, in part, by entering Poland. We talk to Vitaldent adviser Reiner Loeslein about strategy and business models.

Interview: Stuart Fletcher, CEO, Bupa

It has been a busy year for insurer, hospital operator and care group Bupa. New CEO Stuart Fletcher is spending roughly £1.25bn to buy businesses in half a dozen countries across the world. That includes the planned acquisition of Cruz Blanca, a Chilean service provider and insurer, as well as the purchases of Quality HealthCare (a network of 102 outpatient clinics and 500 affiliates in Hong Kong), Richmond Villages (an assisted living business in the UK), LUX MED (the largest subscription healthcare operator in Poland), ten nursing homes in Australia, and dentists here, there and everywhere. All this is part of the Bupa 2020 master plan, which will see the world’s largest player in ex-pat insurance deliver far more integrated care. We talk to Fletcher to find out more.

Interview: Dag Andersson, CEO, Diaverum

With close to 300 dialysis centres in 19 countries, Diaverum's Dag Andersson claims to run “the most global healthcare service in the world”. The company is majority-owned by private equity house Bridgepoint, which hired JP Morgan in January 2013 to review the company's strategic options. We speak to Andersson about Diaverum's future.

Find Us